|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1701 to 1800 out of 3295 for Kras

0.02s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Wiel C
Year: 2019
Journal: Cell
Title: BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis.
Volume: 178
Issue: 2
Pages: 330-345.e22
Publication  
First Author: Kirkpatrick JD
Year: 2020
Journal: Sci Transl Med
Title: Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling.
Volume: 12
Issue: 537
Publication
First Author: Sánchez-Rivera FJ
Year: 2014
Journal: Nature
Title: Rapid modelling of cooperating genetic events in cancer through somatic genome editing.
Volume: 516
Issue: 7531
Pages: 428-31
Publication
First Author: Allegrezza MJ
Year: 2016
Journal: Cancer Res
Title: IL15 Agonists Overcome the Immunosuppressive Effects of MEK Inhibitors.
Volume: 76
Issue: 9
Pages: 2561-72
Publication
First Author: Badea CT
Year: 2012
Journal: PLoS One
Title: Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.
Volume: 7
Issue: 4
Pages: e34496
Publication  
First Author: Scafoglio CR
Year: 2018
Journal: Sci Transl Med
Title: Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.
Volume: 10
Issue: 467
Publication
First Author: Zheng Y
Year: 2013
Journal: Cancer Cell
Title: A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal.
Volume: 24
Issue: 1
Pages: 59-74
Publication
First Author: Sullivan WJ
Year: 2018
Journal: Cell
Title: Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization.
Volume: 175
Issue: 1
Pages: 117-132.e21
Publication
First Author: Kopparam J
Year: 2017
Journal: Cell Death Differ
Title: RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.
Volume: 24
Issue: 10
Pages: 1761-1771
Publication
First Author: Li CM
Year: 2013
Journal: Genes Dev
Title: Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma.
Volume: 27
Issue: 14
Pages: 1557-67
Publication
First Author: Sutherland KD
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.
Volume: 111
Issue: 13
Pages: 4952-7
Publication
First Author: Rhim AD
Year: 2014
Journal: Cancer Cell
Title: Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Volume: 25
Issue: 6
Pages: 735-47
Publication
First Author: Serresi M
Year: 2018
Journal: J Exp Med
Title: Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.
Volume: 215
Issue: 12
Pages: 3115-3135
Publication
First Author: Kim MJ
Year: 2021
Journal: Mol Cell
Title: PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.
Volume: 81
Issue: 8
Pages: 1698-1714.e6
Publication
First Author: Shi M
Year: 2024
Journal: Eur J Immunol
Title: Characterizing dynamic tumor-immune interactions in lung adenocarcinoma through orthotopic allograft modeling.
Volume: 54
Issue: 12
Pages: e2451342
Publication
First Author: Sachdeva M
Year: 2014
Journal: J Clin Invest
Title: MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.
Volume: 124
Issue: 10
Pages: 4305-19
Publication  
First Author: Biancur DE
Year: 2017
Journal: Nat Commun
Title: Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism.
Volume: 8
Pages: 15965
Publication
First Author: Aiello NM
Year: 2018
Journal: Dev Cell
Title: EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.
Volume: 45
Issue: 6
Pages: 681-695.e4
Publication
First Author: Groeneveld S
Year: 2018
Journal: Oncotarget
Title: Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells.
Volume: 9
Issue: 64
Pages: 32331-32345
Publication
First Author: Rowbotham SP
Year: 2018
Journal: Nat Commun
Title: H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression.
Volume: 9
Issue: 1
Pages: 4559
Publication
First Author: Tandon M
Year: 2019
Journal: Cancer Res
Title: Prolactin Promotes Fibrosis and Pancreatic Cancer Progression.
Volume: 79
Issue: 20
Pages: 5316-5327
Publication
First Author: Provenzano PP
Year: 2012
Journal: Cancer Cell
Title: Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.
Volume: 21
Issue: 3
Pages: 418-29
Publication
First Author: Takahashi H
Year: 2010
Journal: Cancer Cell
Title: Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation.
Volume: 17
Issue: 1
Pages: 89-97
Publication
First Author: Yang X
Year: 2020
Journal: Cancer Immunol Res
Title: Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer.
Volume: 8
Issue: 11
Pages: 1440-1451
Publication
First Author: Wahlstrom AM
Year: 2008
Journal: Blood
Title: Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease.
Volume: 112
Issue: 4
Pages: 1357-65
Publication  
First Author: Menon MB
Year: 2021
Journal: Front Cell Dev Biol
Title: Lyz2-Cre-Mediated Genetic Deletion of Septin7 Reveals a Role of Septins in Macrophage Cytokinesis and Kras-Driven Tumorigenesis.
Volume: 9
Pages: 795798
Publication
First Author: Rao S
Year: 2017
Journal: Genes Dev
Title: RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.
Volume: 31
Issue: 20
Pages: 2099-2112
Publication
First Author: Xiao Q
Year: 2015
Journal: PLoS Genet
Title: Minor Type IV Collagen α5 Chain Promotes Cancer Progression through Discoidin Domain Receptor-1.
Volume: 11
Issue: 5
Pages: e1005249
Publication
First Author: Lastwika KJ
Year: 2016
Journal: Cancer Res
Title: Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer.
Volume: 76
Issue: 2
Pages: 227-38
Publication
First Author: Mise N
Year: 2012
Journal: J Biol Chem
Title: Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.
Volume: 287
Issue: 37
Pages: 31393-405
Publication
First Author: Basu SK
Year: 2018
Journal: Cancer Res
Title: Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets.
Volume: 78
Issue: 4
Pages: 891-908
Publication
First Author: Castellano E
Year: 2013
Journal: Cancer Cell
Title: Requirement for interaction of PI3-kinase p110α with RAS in lung tumor maintenance.
Volume: 24
Issue: 5
Pages: 617-30
Publication
First Author: Masri S
Year: 2016
Journal: Cell
Title: Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis.
Volume: 165
Issue: 4
Pages: 896-909
Publication
First Author: Volonte D
Year: 2018
Journal: J Biol Chem
Title: Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
Volume: 293
Issue: 5
Pages: 1794-1809
Publication
First Author: Feldser DM
Year: 2010
Journal: Nature
Title: Stage-specific sensitivity to p53 restoration during lung cancer progression.
Volume: 468
Issue: 7323
Pages: 572-5
Publication
First Author: Chen L
Year: 2018
Journal: Cancer Discov
Title: CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade.
Volume: 8
Issue: 9
Pages: 1156-1175
Publication
First Author: Gibbons DL
Year: 2009
Journal: PLoS One
Title: Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma.
Volume: 4
Issue: 4
Pages: e5401
Publication  
First Author: Riccardo F
Year: 2014
Journal: BMC Genomics
Title: Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.
Volume: 15 Suppl 3
Pages: S1
Publication
First Author: Trejo CL
Year: 2012
Journal: Cancer Res
Title: MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.
Volume: 72
Issue: 12
Pages: 3048-59
Publication  
First Author: Shurell E
Year: 2014
Journal: BMC Cancer
Title: Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients.
Volume: 14
Pages: 827
Publication
First Author: Blum JS
Year: 2011
Journal: Drug Deliv Transl Res
Title: Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles.
Volume: 1
Issue: 5
Pages: 383-394
Publication
First Author: Sengupta P
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.
Volume: 109
Issue: 28
Pages: 11294-9
Publication
First Author: Chen M
Year: 2017
Journal: Hum Gene Ther Methods
Title: Efficient Gene Delivery and Expression in Pancreas and Pancreatic Tumors by Capsid-Optimized AAV8 Vectors.
Volume: 28
Issue: 1
Pages: 49-59
Publication  
First Author: Lau L
Year: 2019
Journal: Mol Cell Biol
Title: Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
Volume: 39
Issue: 12
Publication
First Author: Gough DJ
Year: 2014
Journal: Blood
Title: STAT3 supports experimental K-RasG12D-induced murine myeloproliferative neoplasms dependent on serine phosphorylation.
Volume: 124
Issue: 14
Pages: 2252-61
Publication
First Author: Makino Y
Year: 2018
Journal: Cancer Res
Title: CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Volume: 78
Issue: 17
Pages: 4902-4914
Publication
First Author: Vitos-Faleato J
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Requirement for epithelial p38α in KRAS-driven lung tumor progression.
Volume: 117
Issue: 5
Pages: 2588-2596
Publication  
First Author: Kemp SB
Year: 2021
Journal: Life Sci Alliance
Title: Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages.
Volume: 4
Issue: 6
Publication
First Author: Kamata T
Year: 2020
Journal: Cell Rep
Title: Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development.
Volume: 31
Issue: 12
Pages: 107802
Publication
First Author: Kato H
Year: 2020
Journal: Cancer Genomics Proteomics
Title: Deletion of Histone Methyltransferase G9a Suppresses Mutant Kras-driven Pancreatic Carcinogenesis.
Volume: 17
Issue: 6
Pages: 695-705
Publication
First Author: Corcoran RB
Year: 2011
Journal: Cancer Res
Title: STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.
Volume: 71
Issue: 14
Pages: 5020-9
Publication
First Author: Lu SL
Year: 2006
Journal: Genes Dev
Title: Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Volume: 20
Issue: 10
Pages: 1331-42
Publication
First Author: Yoo S
Year: 2022
Journal: Nat Commun
Title: Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression.
Volume: 13
Issue: 1
Pages: 1592
Publication
First Author: Vincent DF
Year: 2012
Journal: Am J Pathol
Title: Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.
Volume: 180
Issue: 6
Pages: 2214-21
Publication
First Author: De la Garza MM
Year: 2018
Journal: Oncotarget
Title: COPD-Type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1α mediated tumor angiogenesis and proliferation.
Volume: 9
Issue: 68
Pages: 32972-32983
Publication  
First Author: Qiu W
Year: 2018
Journal: Cancer Lett
Title: Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice.
Volume: 423
Pages: 71-79
Publication
First Author: Stoy C
Year: 2015
Journal: EMBO Mol Med
Title: Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy.
Volume: 7
Issue: 8
Pages: 1048-62
Publication
First Author: Nacarelli T
Year: 2019
Journal: Nat Cell Biol
Title: NAD+ metabolism governs the proinflammatory senescence-associated secretome.
Volume: 21
Issue: 3
Pages: 397-407
Publication
First Author: Rao CV
Year: 2016
Journal: Cancer Res
Title: Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.
Volume: 76
Issue: 7
Pages: 1965-74
Publication
First Author: Drosos Y
Year: 2016
Journal: Neoplasia
Title: Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.
Volume: 18
Issue: 3
Pages: 172-84
Publication
First Author: Borghesan M
Year: 2019
Journal: Cell Rep
Title: Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3.
Volume: 27
Issue: 13
Pages: 3956-3971.e6
Publication
First Author: Pylayeva-Gupta Y
Year: 2012
Journal: Cancer Cell
Title: Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.
Volume: 21
Issue: 6
Pages: 836-47
Publication
First Author: Dutruel C
Year: 2014
Journal: Oncogene
Title: Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
Volume: 33
Issue: 26
Pages: 3401-10
Publication
First Author: Tong X
Year: 2021
Journal: EMBO Mol Med
Title: Nanog maintains stemness of Lkb1-deficient lung adenocarcinoma and prevents gastric differentiation.
Volume: 13
Issue: 3
Pages: e12627
Publication
First Author: Stromnes IM
Year: 2015
Journal: Cancer Cell
Title: T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.
Volume: 28
Issue: 5
Pages: 638-652
Publication
First Author: Gitto SB
Year: 2020
Journal: Cell Commun Signal
Title: Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells.
Volume: 18
Issue: 1
Pages: 95
Publication
First Author: Sales KU
Year: 2015
Journal: Oncogene
Title: Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis.
Volume: 34
Issue: 3
Pages: 346-56
Publication
First Author: Li L
Year: 2018
Journal: Cancer Cell
Title: GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.
Volume: 33
Issue: 4
Pages: 736-751.e5
Publication
First Author: Wong PP
Year: 2015
Journal: Cancer Cell
Title: Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.
Volume: 27
Issue: 1
Pages: 123-37
Publication
First Author: Tran K
Year: 2013
Journal: Carcinogenesis
Title: The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer.
Volume: 34
Issue: 1
Pages: 199-210
Publication
First Author: Nobis M
Year: 2013
Journal: Cancer Res
Title: Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer.
Volume: 73
Issue: 15
Pages: 4674-86
Publication
First Author: Fu S
Year: 2023
Journal: Cancer Immunol Res
Title: Syntaphilin Regulates Neutrophil Migration in Cancer.
Volume: 11
Issue: 3
Pages: 278-289
Publication
First Author: Dineen SP
Year: 2010
Journal: Cancer Res
Title: Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.
Volume: 70
Issue: 7
Pages: 2852-61
Publication
First Author: Wang YT
Year: 2017
Journal: J Clin Invest
Title: Ubiquitination of tumor suppressor PML regulates prometastatic and immunosuppressive tumor microenvironment.
Volume: 127
Issue: 8
Pages: 2982-2997
Publication
First Author: Cong J
Year: 2018
Journal: Cell Metab
Title: Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression.
Volume: 28
Issue: 2
Pages: 243-255.e5
Publication
First Author: Courtin A
Year: 2013
Journal: PLoS One
Title: Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Volume: 8
Issue: 6
Pages: e67330
Publication
First Author: Li J
Year: 2023
Journal: Cell Death Differ
Title: Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway.
Volume: 30
Issue: 2
Pages: 313-326
Publication
First Author: Guillaumond F
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.
Volume: 110
Issue: 10
Pages: 3919-24
Publication
First Author: Ding B
Year: 2019
Journal: Oncotarget
Title: p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis.
Volume: 10
Issue: 65
Pages: 6997-7009
Publication  
First Author: Leal AS
Year: 2017
Journal: Cancer Lett
Title: Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer.
Volume: 394
Pages: 76-87
Publication
First Author: DuFort CC
Year: 2016
Journal: Cancer Cell
Title: Tension and Transformation in Pancreas Cancer: Can Phenotype Break Free from the Chrysalis of Genotype?
Volume: 29
Issue: 6
Pages: 780-782
Publication  
First Author: Yang D
Year: 2023
Journal: Cancers (Basel)
Title: Cross-Dataset Single-Cell Analysis Identifies Temporal Alterations in Cell Populations of Primary Pancreatic Tumor and Liver Metastasis.
Volume: 15
Issue: 8
Publication  
First Author: Fabian A
Year: 2019
Journal: Cancer Lett
Title: Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells.
Volume: 453
Pages: 95-106
Publication
First Author: Guillaumond F
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
Volume: 112
Issue: 8
Pages: 2473-8
Publication
First Author: Jiang SH
Year: 2017
Journal: Gastroenterology
Title: Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Volume: 153
Issue: 1
Pages: 277-291.e19
Publication  
First Author: Chen X
Year: 2017
Journal: Cancer Lett
Title: Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
Volume: 399
Pages: 20-28
Publication
First Author: Elahi-Gedwillo KY
Year: 2019
Journal: Cancer Res
Title: Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
Volume: 79
Issue: 2
Pages: 372-386
Publication
First Author: Liao J
Year: 2016
Journal: Anticancer Res
Title: Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
Volume: 36
Issue: 1
Pages: 27-37
Publication
First Author: Cao XY
Year: 2018
Journal: Biochem Biophys Res Commun
Title: Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Volume: 499
Issue: 3
Pages: 584-593
Publication
First Author: He D
Year: 2022
Journal: Mol Cell
Title: Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.
Volume: 82
Issue: 16
Pages: 3045-3060.e11
Publication
First Author: Sainz B Jr
Year: 2014
Journal: Cancer Res
Title: ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
Volume: 74
Issue: 24
Pages: 7309-20
Publication
First Author: Soucek L
Year: 2013
Journal: Genes Dev
Title: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.
Volume: 27
Issue: 5
Pages: 504-13
Publication
First Author: Olive KP
Year: 2009
Journal: Science
Title: Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Volume: 324
Issue: 5933
Pages: 1457-61
Publication
First Author: Soucek L
Year: 2008
Journal: Nature
Title: Modelling Myc inhibition as a cancer therapy.
Volume: 455
Issue: 7213
Pages: 679-83
Publication
First Author: Fendrich V
Year: 2011
Journal: Neoplasia
Title: Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
Volume: 13
Issue: 2
Pages: 180-6
Publication
First Author: He F
Year: 2023
Journal: Cancer Res
Title: FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.
Volume: 83
Issue: 10
Pages: 1628-1645
Publication
First Author: Palm W
Year: 2015
Journal: Cell
Title: The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Volume: 162
Issue: 2
Pages: 259-270
Publication
First Author: Roe JS
Year: 2017
Journal: Cell
Title: Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis.
Volume: 170
Issue: 5
Pages: 875-888.e20
Publication
First Author: Yamaguchi J
Year: 2024
Journal: Cancer Med
Title: Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer.
Volume: 13
Issue: 11
Pages: e7395
Publication  
First Author: Jiang SH
Year: 2022
Journal: EBioMedicine
Title: Modeling of cancer-related body-wide effects identifies LTB4 as a diagnostic biomarker for pancreatic cancer.
Volume: 80
Pages: 104050